Skip to main content
. 2021 Mar 17;320(5):G907–G918. doi: 10.1152/ajpgi.00284.2020

Figure 2.

Figure 2.

Serum triglyceride (A) and cholesterol (B) levels in C57BL/6J sham (n = 5, 5) and small bowel resection (SBR) (n = 5, 6) mice and in 129S1/SvImJ sham (n = 8, 8) and SBR (n = 5, 5) mice at postoperative weeks 5 and 10–12 (noted as 10 wk), respectively. Hepatic triglyceride (C), cholesterol (D), and free fatty acids (E) in sham C57BL/6J (n = 6) and SBR (n = 6) mice and in sham 129S1/SvImJ (n = 7) and SBR (n = 5) mice at 10-wk postoperatively. F: representative hematoxylin and eosin (H&E) images of livers in C57BL/6J and 129S1/SvImJ mice at 10-wk postoperatively showing increased lipid droplets with micro/macrovesicular steatosis, dysregulated hepatocytes, and infiltration of small nucleus immune cells in C57BL/6J SBR livers compared with their sham controls as well as both experimental groups in the 129S1/SvImJ line. ***P = 0.001, **P < 0.005, *P < 0.05.